Report error Found 105 Enz. Inhib. hit(s) with all data for entry = 12882
Affinity DataIC50: 14nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 28nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 29nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 31nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 34nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 37nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 38nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 42nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 47nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 47nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 48nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 51nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 51nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 51nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 53nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 53nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 55nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 56nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 56nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 56nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 57nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 58nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 58nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 61nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 64nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 75nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 76nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 76nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 78nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 78nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 79nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 84nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 88nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 90nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 91nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
Affinity DataIC50: 93nMAssay Description:Compounds of the invention were dissolved in DMSO at a concentration of 3 mM with subsequent dilutions in assay buffer (50 mM HEPES PH7.0, 150 mM NaC...More data for this Ligand-Target Pair
